Advisory Committee to the Director (ACD), Centers for Disease Control and Prevention (CDC)-Ethics Subcommittee (ES), 57044 [2010-23228]
Download as PDF
<![CDATA[
57044
Federal Register / Vol. 75, No. 180 / Friday, September 17, 2010 / Notices
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Neurological Disorders and Stroke Special
Emphasis Panel; EUREKA.
Date: November 8, 2010.
Time: 8 a.m. to 6 p.m.
Agenda: To review and evaluate grant
applications.
Place: Amalfi Hotel, 200 West Kinzie
Street, Chicago, IL 60654.
Contact Person: William C. Benzing, PhD,
Scientific Review Administrator, Scientific
Review Branch, DHHS/NIH/NINDS/DER/
SRB, Neuroscience Center, 6001 Executive
Blvd., Suite 3204, MSC 9529, Bethesda, MD
20892, 301–496–0660,
Benzingw@mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.853, Clinical Research
Related to Neurological Disorders; 93.854,
Biological Basis Research in the
Neurosciences, National Institutes of Health,
HHS)
Dated: September 10, 2010.
Jennifer S. Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 2010–23268 Filed 9–16–10; 8:45 am]
Contact Person: Enid Light, PhD, Scientific
Review Officer, Division of Extramural
Activities, National Institute of Mental
Health, NIH, Neuroscience Center, 6001
Executive Boulevard, Room 6132, MSC 9608,
Bethesda, MD 20852, 301–443–3599,
elight@mail.nih.gov.
Name of Committee: National Institute of
Mental Health Special Emphasis Panel
Developing & Advance Centers for
Intervention and Services Research.
Date: October 22, 2010.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: Embassy Suites at the Chevy Chase
Pavilion, 4300 Military Road, NW.,
Washington, DC 20015.
Contact Person: Francois Boller, MD, PhD,
Scientific Review Officer, Division of
Extramural Activities, National Institute of
Mental Health, NIH, Neuroscience Center,
6001 Executive Blvd., Room 6142, MSC 9606,
Bethesda, MD 20892–9606, 301–443–1513,
bollerf@mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.242, Mental Health Research
Grants; 93.281, Scientist Development
Award, Scientist Development Award for
Clinicians, and Research Scientist Award;
93.282, Mental Health National Research
Service Awards for Research Training,
National Institutes of Health, HHS)
Dated: September 10, 2010.
Jennifer S. Spaeth,
Director, Office of Federal Advisory
Committee Policy.
BILLING CODE 4140–01–P
public comment periods are tentatively
scheduled for 4 p.m.–4:15 p.m. on October 7,
2010 and from 12 p.m.–12:15 p.m. on
October 8, 2010.
Purpose: The ES will provide counsel to
the ACD, CDC, regarding a broad range of
public health ethics questions and issues
arising from programs, scientists and
practitioners.
Matter To Be Discussed: Agenda items will
include the following topics: Plans for
obtaining public comment on the ventilator
guidance document; efforts to support state,
tribal, local and territorial health
departments address ethical issues in the
practice of public health; and ethical issues
relating to patient notification following
infection control lapses.
The agenda is subject to change as
priorities dictate.
Contact Person for More Information: For
security reasons, members of the public
interested in attending the meeting should
contact Drue Barrett, PhD, Designated
Federal Official, ACD, CDC–ES, 1600 Clifton
Road, NE., M/S D–50, Atlanta, Georgia
30333. Telephone (404) 639–4690. E-mail:
dbarrett@cdc.gov. The deadline for
notification of attendance is October 1, 2010.
The Director, Management Analysis and
Services Office, has been delegated the
authority to sign Federal Register notices
pertaining to announcements of meetings and
other committee management activities, for
both the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
BILLING CODE 4140–01–P
Dated: September 10, 2010.
Elaine L. Baker,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
National Institute of Mental Health;
Notice of Closed Meetings
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
[FR Doc. 2010–23228 Filed 9–16–10; 8:45 am]
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Centers for Disease Control and
Prevention
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
[FR Doc. 2010–23265 Filed 9–16–10; 8:45 am]
wwoods2 on DSK1DXX6B1PROD with NOTICES_PART 1
National Institutes of Health
Name of Committee: National Institute of
Mental Health Special Emphasis Panel
Fellowships and Dissertations.
Date: October 13, 2010.
Time: 11 a.m. to 12:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Neuroscience Center, 6001 Executive
Boulevard, Rockville, MD 20852 (Telephone
Conference Call).
VerDate Mar<15>2010
14:46 Sep 16, 2010
Jkt 220001
Advisory Committee to the Director
(ACD), Centers for Disease Control and
Prevention (CDC)—Ethics
Subcommittee (ES)
In accordance with section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the CDC announces
the following meeting of the
aforementioned subcommittee:
Times and Dates: 1 p.m.–5 p.m., October
7, 2010; 8:30 a.m.–12:30 p.m., October 8,
2010.
Place: CDC, Thomas R. Harkin Global
Communications Center, Distance Learning
Auditorium, 1600 Clifton Road, NE., Atlanta,
GA 30333. This meeting is also available by
teleconference. Please dial (877) 928–1204
and enter code 4305992.
Status: Open to the public, limited only by
the space available. The meeting room
accommodates approximately 60 people. To
accommodate public participation in the
meeting, a conference telephone line will be
available. The public is welcome to
participate during the public comment. The
PO 00000
Frm 00066
Fmt 4703
Sfmt 4703
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
NIOSH List of Antineoplastic and Other
Hazardous Drugs in Healthcare
Settings 2010
National Institute for
Occupational Safety and Health
(NIOSH) of the Centers for Disease
Control and Prevention (CDC),
Department of Health and Human
Services (HHS).
ACTION: Notice of Final Document.
AGENCY:
The National Institute for
Occupational Safety and Health
(NIOSH) of the Centers for Disease
Control and Prevention (CDC)
announces the publication of the
following document entitled ‘‘NIOSH
List of Antineoplastic and Other
Hazardous Drugs in Healthcare Settings
2010.’’ The document can be found at
SUMMARY:
E:\FR\FM\17SEN1.SGM
17SEN1
]]>Agencies
[Federal Register Volume 75, Number 180 (Friday, September 17, 2010)]
[Notices]
[Page 57044]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2010-23228]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Advisory Committee to the Director (ACD), Centers for Disease
Control and Prevention (CDC)--Ethics Subcommittee (ES)
In accordance with section 10(a)(2) of the Federal Advisory
Committee Act (Pub. L. 92-463), the CDC announces the following meeting
of the aforementioned subcommittee:
Times and Dates: 1 p.m.-5 p.m., October 7, 2010; 8:30 a.m.-12:30
p.m., October 8, 2010.
Place: CDC, Thomas R. Harkin Global Communications Center,
Distance Learning Auditorium, 1600 Clifton Road, NE., Atlanta, GA
30333. This meeting is also available by teleconference. Please dial
(877) 928-1204 and enter code 4305992.
Status: Open to the public, limited only by the space available.
The meeting room accommodates approximately 60 people. To
accommodate public participation in the meeting, a conference
telephone line will be available. The public is welcome to
participate during the public comment. The public comment periods
are tentatively scheduled for 4 p.m.-4:15 p.m. on October 7, 2010
and from 12 p.m.-12:15 p.m. on October 8, 2010.
Purpose: The ES will provide counsel to the ACD, CDC, regarding
a broad range of public health ethics questions and issues arising
from programs, scientists and practitioners.
Matter To Be Discussed: Agenda items will include the following
topics: Plans for obtaining public comment on the ventilator
guidance document; efforts to support state, tribal, local and
territorial health departments address ethical issues in the
practice of public health; and ethical issues relating to patient
notification following infection control lapses.
The agenda is subject to change as priorities dictate.
Contact Person for More Information: For security reasons,
members of the public interested in attending the meeting should
contact Drue Barrett, PhD, Designated Federal Official, ACD, CDC-ES,
1600 Clifton Road, NE., M/S D-50, Atlanta, Georgia 30333. Telephone
(404) 639-4690. E-mail: dbarrett@cdc.gov. The deadline for
notification of attendance is October 1, 2010.
The Director, Management Analysis and Services Office, has been
delegated the authority to sign Federal Register notices pertaining
to announcements of meetings and other committee management
activities, for both the Centers for Disease Control and Prevention
and the Agency for Toxic Substances and Disease Registry.
Dated: September 10, 2010.
Elaine L. Baker,
Director, Management Analysis and Services Office, Centers for Disease
Control and Prevention.
[FR Doc. 2010-23228 Filed 9-16-10; 8:45 am]
BILLING CODE 4163-18-P
